Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,164,908
  • Shares Outstanding, K 209,049
  • Annual Sales, $ 3,723 M
  • Annual Income, $ 722,200 K
  • 36-Month Beta 0.92
  • Price/Sales 9.89
  • Price/Cash Flow 41.34
  • Price/Book 11.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.23
  • Number of Estimates 10
  • High Estimate 1.30
  • Low Estimate 1.20
  • Prior Year 1.22
  • Growth Rate Est. (year over year) +0.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.08 +8.61%
on 02/01/19
178.68 -0.87%
on 02/19/19
+8.71 (+5.17%)
since 01/18/19
3-Month
139.64 +26.84%
on 12/24/18
178.68 -0.87%
on 02/19/19
+27.24 (+18.17%)
since 11/19/18
52-Week
123.00 +44.00%
on 04/25/18
178.68 -0.87%
on 02/19/19
+43.30 (+32.36%)
since 02/16/18

Most Recent Stories

More News
CAS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CAS Medical Systems, Inc. - CASM

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of CAS Medical Systems, Inc. (NasdaqCM: CASM) ("CASMed")...

EW : 177.15 (-0.35%)
CASM : 2.42 (+0.41%)
Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm

The CASMED buyout is expected to strengthen Edwards Lifesciences' (EW) position in smart monitoring technologies and boost top-line contributions from the Critical Care arm.

EW : 177.15 (-0.35%)
ABT : 75.09 (-0.21%)
AMED : 132.36 (-2.83%)
PEN : 151.42 (-2.67%)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of CAS Medical Systems, Inc. (CASM) on Behalf of Stockholders and Encourages CASM Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of CAS Medical Systems, Inc. (NASDAQ: CASM) on behalf of stockholders concerning the proposed acquisition of...

EW : 177.15 (-0.35%)
CASM : 2.42 (+0.41%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of CAS Medical Systems, Inc.

Rowley Law PLLC is investigating potential claims against CAS Medical Systems, Inc. (NASDAQ: CASM) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company...

EW : 177.15 (-0.35%)
CASM : 2.42 (+0.41%)
Edwards Lifesciences Enters Into Agreement To Acquire CASMED

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has entered into a definitive...

EW : 177.15 (-0.35%)
CASM : 2.42 (+0.41%)
MDSY : 0.73 (+4.29%)
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?

Style Box ETF report for JHMM

UAL : 89.51 (+1.36%)
EW : 177.15 (-0.35%)
IJH : 192.02 (+0.29%)
VO : 159.08 (+0.42%)
JHMM : 35.03 (+0.32%)
Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Brands, Radius Health, Kaman, and FARO Technologies -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Edwards Lifesciences Corporation...

ZBH : 123.86 (+0.17%)
AOBC : 12.91 (+1.97%)
EW : 177.15 (-0.35%)
KAMN : 62.42 (+2.29%)
RDUS : 18.65 (+1.97%)
FARO : 48.02 (+1.85%)
Boston Scientific Announces Results For Fourth Quarter And Full Year 2018

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.561 billion during the fourth quarter of 2018. This represents growth of 6.3 percent on a reported basis, 8.2 percent on an operational1...

EW : 177.15 (-0.35%)
BTG : 3.14 (+4.32%)
BSX : 39.86 (-0.37%)
Top 5 Companies in the Health Care Equipment Industry with the Best Relative Performance (NUVA , DXCM , EW , WMGI , TNDM)

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

EW : 177.15 (-0.35%)
TNDM : 49.55 (-3.79%)
NUVA : 57.63 (-1.64%)
DXCM : 148.14 (-0.24%)
Edwards Lifesciences (EW) Q4 Earnings In Line, Revenues Top

Edwards Lifesciences (EW) Q4 results benefit from growth in all the businesses.

EW : 177.15 (-0.35%)
VAR : 132.13 (-0.46%)
ANGO : 23.34 (-0.51%)
CNMD : 75.01 (+4.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade EW with:

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 179.89
1st Resistance Point 178.83
Last Price 177.15
1st Support Level 176.51
2nd Support Level 175.25

See More

52-Week High 178.68
Last Price 177.15
Fibonacci 61.8% 157.41
Fibonacci 50% 150.84
Fibonacci 38.2% 144.27
52-Week Low 123.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar